Evidence explainerVitamin K2 (MK-7 vs MK-4)
Can Vitamin K2 Keep Calcium Out of Your Arteries? What 14 Trials Actually Show
K2 is sold as the vitamin that steers calcium away from your arteries. The trial evidence is real but thin, borderline and not form-specific. Here is the fair read.
Key takeaways
- A 2023 meta-analysis of 14 trials (1,533 people) found coronary artery calcium scores progressed less with vitamin K, at borderline statistical significance (p = 0.04) [1].
- That analysis did not separate vitamin K forms or populations in its abstract, so it is not specific to K2 [1].
- In one 3-year trial of 244 healthy postmenopausal women, 180 mcg/day of MK-7 lowered arterial stiffness measures versus placebo [2].
- Vitamin K counteracts warfarin; anyone on it needs their prescriber before adding K2 [3].
Safety at a glance
From our Vitamin K2 (MK-7 vs MK-4) monograph. Published interactions and cautions only, each with its source.
Interactions
- Warfarin and similar anticoagulants. Serious, potentially dangerous interaction: vitamin K counteracts these drugs, so sudden changes in vitamin K intake can change their effect. A study of MK-7 warned that 50 mcg/day or more may interfere with oral anticoagulant treatment in a clinically relevant way.[1][7]
- Antibiotics. Can destroy vitamin K-producing gut bacteria and may lower vitamin K status, especially with prolonged use and poor intake.[1]
- Bile acid sequestrants. Can reduce absorption of vitamin K and other fat-soluble vitamins.[1]
- Orlistat. Reduces absorption of fat-soluble vitamins including vitamin K; orlistat with warfarin might markedly raise prothrombin time.[1]
Who should be careful
- People on warfarin or similar anticoagulants. Do not start, stop or change a vitamin K2 supplement without your prescriber. Even 50 mcg/day of MK-7 may affect anticoagulation.[1][7]
- Pregnancy and breastfeeding. The AI is 90 mcg/day for adults 19+ in pregnancy and breastfeeding; no UL is set. Pregnancy-specific trial data for K2 supplements are not in our sources.[1]
- Malabsorption or bariatric surgery. People with malabsorption conditions or after bariatric surgery may have low vitamin K status and may need clinician monitoring.[1]
- Before you start. Talk to your pharmacist or clinician before adding this supplement, especially if you take prescription medicines, are pregnant or breastfeeding, or have a chronic health condition.[1]
The evidence, graded
Pulled from our monograph evidence tables. Grades follow our evidence-grading policy.
- Grade CImprovedCoronary artery calcium score progression (any vitamin K form)Coronary artery calcium scores progressed less with vitamin K (MD -17.37; p = 0.04) and dp-ucMGP fell; adverse events did not differ from control.
- Grade CImprovedArterial stiffness with MK-7Carotid-femoral pulse wave velocity and stiffness index β decreased versus placebo; more local stiffness measures improved in women with higher baseline stiffness. dp-ucMGP fell 50% versus placebo; inflammation and endothelial markers did not change.
The theory: matrix Gla protein
Matrix Gla protein (MGP) is a vitamin K-dependent protein found in vascular smooth muscle, bone and cartilage, and NIH says it is the focus of research because it might help reduce abnormal calcification [3]. Vitamin K is needed to activate it. When vitamin K is short, more MGP circulates in an inactive form, measured in trials as dp-ucMGP [2].
The calcium-score evidence
The best summary is a 2023 meta-analysis of 14 randomized trials with 1,533 participants [1]. Coronary artery calcium scores progressed less with vitamin K than with control (mean difference -17.37), and inactive MGP fell, with no difference in adverse events [1]. The p-value was 0.04, which is borderline, and the authors called for more rigorous trials [1].
The abstract does not break results down by vitamin K form or by who was studied, so we cannot say how much of this applies to MK-7 or MK-4 specifically [1]. That is why we grade it C on the vitamin K2 monograph.
The arterial stiffness trial
In 244 healthy postmenopausal women followed for 3 years, 180 mcg/day of MK-7 lowered carotid-femoral pulse wave velocity and the stiffness index beta compared with placebo [2]. Inactive MGP fell 50% versus placebo, while inflammation and blood-vessel lining markers did not change [2]. This was a secondary analysis of the same cohort as the MK-7 bone trial, so it is one trial, not two [2].
What this means for you
The direction is encouraging and adverse events did not differ from control [1]. But stiffness and calcium scores are measurements, not heart attacks or strokes, and no trial in our sources shows vitamin K2 changes those outcomes [1][2]. If your clinician has flagged a high calcium score, that conversation should cover proven options first.
Safety is straightforward except for warfarin, where NIH calls the interaction serious [3]. Compare forms in MK-7 vs MK-4, or see how K2 is paired with vitamin D in D3 and K2 together. Omega-3s are another popular heart supplement with a surprising twist: fish oil after 50.
Keep reading
Full monographs
Related articles
- MK-7 vs MK-4: The Two Kinds of Vitamin K2, and Why Their Doses Differ a Thousandfold
- Vitamin D3 and K2 Together: Smart Pairing or Marketing? What the Research Actually Shows
- 400 IU of Vitamin E Is Either 268 mg or 180 mg. The "d" or "dl" on the Label Decides
- B12 After 50 and on Metformin: Why Levels Drop, and What the Trials Say About Fixing Them
Browse the full Supplement & Nutrient Encyclopedia or all supplement articles.
References
- [1]Vitamin K supplementation and vascular calcification: a systematic review and meta-analysis of randomized controlled trials. Front Nutr, 2023.
- [2]Menaquinone-7 supplementation improves arterial stiffness in healthy postmenopausal women. A double-blind randomised clinical trial. Thromb Haemost, 2015.
- [3]Vitamin K: Fact Sheet for Health Professionals. NIH Office of Dietary Supplements, 2021.